Ideaya Biosciences Inc (IDYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -113,698 | -274,477 | -112,961 | -58,655 | -49,762 |
| Depreciation Amortization | -5,383 | -19,399 | -7,545 | 2,820 | 3,559 |
| Accounts receivable | N/A | N/A | 193 | 892 | 774 |
| Accounts payable and accrued liabilities | 2,697 | 8,280 | 2,635 | 1,864 | 1,166 |
| Other Working Capital | 1,868 | 11,546 | -13,207 | -42,969 | -17,813 |
| Other Operating Activity | 43,418 | 26,466 | 15,661 | 8,873 | 6,297 |
| Operating Cash Flow | $-71,098 | $-247,584 | $-115,224 | $-87,175 | $-55,779 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 72,344 | -498,702 | -156,088 | -29,961 | -67,022 |
| PPE Investments | -2,368 | -3,857 | -2,368 | -3,443 | -2,644 |
| Investing Cash Flow | $69,976 | $-502,559 | $-158,456 | $-33,404 | $-69,666 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 28,286 | 676,112 | 361,504 | 96,410 | 144,757 |
| Other Financing Activity | 1,493 | 1,439 | 1,213 | 755 | 697 |
| Financing Cash Flow | $29,779 | $677,551 | $362,717 | $97,165 | $145,454 |
| Beginning Cash Position | 85,183 | 157,775 | 68,738 | 92,152 | 72,143 |
| End Cash Position | 113,840 | 85,183 | 157,775 | 68,738 | 92,152 |
| Net Cash Flow | $28,657 | $-72,592 | $89,037 | $-23,414 | $20,009 |
| Free Cash Flow | |||||
| Operating Cash Flow | -71,098 | -247,584 | -115,224 | -87,175 | -55,779 |
| Capital Expenditure | -2,368 | -3,857 | -2,368 | -3,443 | -2,644 |
| Free Cash Flow | -73,466 | -251,441 | -117,592 | -90,618 | -58,423 |